(XMME) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Etf • ISIN: IE00BTJRMP35
XMME: Equities, Cash, Dividends, Shares
The Xtrackers MSCI Emerging Markets UCITS ETF 1C CHF (XMME) is designed to track the performance of the MSCI Emerging Markets Index, offering exposure to a broad range of emerging market equities. Listed on the SIX Swiss Exchange under the ticker symbol XMME, this ETF is structured as a UCITS-compliant fund, adhering to European Union regulations for Undertakings for Collective Investment in Transferable Securities.
From a technical perspective, XMMEs SMA20 of 47.87 is below its SMA50 of 50.88 and SMA200 of 50.78, indicating a potential bearish trend. The ATR of 1.08 reflects moderate volatility, suggesting that price movements are relatively stable but could see an increase in the near term.
Fundamentally, XMME manages an AUM of 5,979.24M CHF, demonstrating significant investor confidence and liquidity. The ETF employs physical replication, holding the underlying securities of the MSCI Emerging Markets Index, and distributes income annually, aligning with the income strategies of many investors.
Over the next three months, based on the current technical setup, XMME may experience a decline in price as the SMA20 continues below the SMA50 and SMA200, signaling bearish momentum. The ATR suggests that volatility might increase, leading to potential price swings. However, the strong AUM reflects underlying strength, which could provide stability against significant downturns.
Additional Sources for XMME ETF
XMME ETF Overview
Market Cap in USD | 7,174m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2017-06-21 |
XMME ETF Ratings
Growth Rating | 1.54 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -11.1 |
Analysts | - |
Fair Price Momentum | 44.21 CHF |
Fair Price DCF | - |
XMME Dividends
Currently no dividends paidXMME Growth Ratios
Growth Correlation 3m | -37.9% |
Growth Correlation 12m | 26.9% |
Growth Correlation 5y | -30.9% |
CAGR 5y | 2.99% |
CAGR/Max DD 5y | 0.09 |
Sharpe Ratio 12m | 0.14 |
Alpha | -9.59 |
Beta | 0.644 |
Volatility | 15.15% |
Current Volume | 1.2k |
Average Volume 20d | 3k |
As of June 01, 2025, the stock is trading at CHF 50.55 with a total of 1,155 shares traded.
Over the past week, the price has changed by -1.04%, over one month by +4.37%, over three months by -5.02% and over the past year by +1.06%.
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.54 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XMME is around 44.21 CHF . This means that XMME is currently overvalued and has a potential downside of -12.54%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, XMME Xtrackers MSCI Emerging will be worth about 50.2 in June 2026. The stock is currently trading at 50.55. This means that the stock has a potential downside of -0.69%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 50.2 | -0.7% |